Widya Mulyasasmita
Plus aucun poste en cours
Profil
Widya Mulyasasmita was the founder of OliLux Biosciences Inc (2019) and LapIQ (2012), where she held the titles of Advisor and Chief Scientist, respectively.
Dr. Mulyasasmita is also the founder of BEVC Management LLC.
Currently, Dr. Mulyasasmita holds multiple positions, including Director at Oncomyx Therapeutics, Inc. (2021 - present), Director at Triumvira Immunologics USA, Inc. (2022 - present), Sr. Principal & Healthcare at B Capital Group Management LP (2021 - present), and Advisor at Partillion Bioscience Corp.
(2020 - present).
Dr. Mulyasasmita's former positions include Director & New Ventures at Johnson & Johnson (2015 - 2018), Chief Business Officer at Venn Biosciences Corp.
(2018 - 2019), and Vice President at Red Tree Venture Capital (2020 - 2021).
Dr. Mulyasasmita received a doctorate from Stanford University and an undergraduate degree from the University of California, Berkeley.
Postes actifs de Widya Mulyasasmita
| Sociétés | Poste | Début |
|---|---|---|
B Capital Group Management LP
 B Capital Group Management LP Investment ManagersFinance B Capital Group Management LP is a private equity and venture capital firm founded in 2014 by Howard Lee Morgan, Raj Ganguly, Eduardo Saverin. The firm is headquartered in Manhattan Beach, California. | Private Equity Investor | 01/09/2021 |
Triumvira Immunologics USA, Inc.
 Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Directeur/Membre du Conseil | 01/03/2022 |
Oncomyx Therapeutics, Inc.
 Oncomyx Therapeutics, Inc. Packaged SoftwareTechnology Services Oncomyx Therapeutics, Inc. develops and operates software platform to orchestrate an immune response and treat cancer. Its platform's features include non-human pathogen, immuno-stimulatory, ability to multi-arm, and systemic delivery. The company was founded by Steve Potts, Michael Wood, Grant McFadden and is headquartered in Phoenix, AZ. | Directeur/Membre du Conseil | 01/11/2021 |
Partillion Bioscience Corp.
 Partillion Bioscience Corp. Miscellaneous Commercial ServicesCommercial Services Partillion Bioscience Corp. is an American company that specializes in providing a functional single-cell biology reagent platform. The company's nanovial technology allows for single-cell secretion analysis and other research capabilities. The company was founded by Joseph Michael de Rutte and Dino Di Carlo, with Joseph Michael de Rutte serving as CEO since incorporation. | Consultant / Advisor | 01/07/2020 |
Anciens postes connus de Widya Mulyasasmita
| Sociétés | Poste | Fin |
|---|---|---|
Red Tree Venture Capital
 Red Tree Venture Capital Investment ManagersFinance Red Tree Venture Capital is a venture capital firm founded by Heath Lukatch. The firm is headquartered in portola, California. | Private Equity Investor | 01/09/2021 |
| OliLux Biosciences Inc | Fondateur | 01/09/2021 |
Venn Biosciences Corp.
 Venn Biosciences Corp. BiotechnologyHealth Technology Venn Biosciences Corp. engages in developing an artificial intelligence-driven mass spectrometry discovery and validation platform. Its products include VENN Vista, a glycoproteomic analysis; OpenPIP software, a neural network for automated mass spectrometry peak integration; and cancer liquid biopsy. The company was founded by Lieza Denan, Aldo Carrascoso, Carlito B. Lebrilla, and Carolyn R. Bertozzi in June 2017 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/11/2019 |
| JOHNSON & JOHNSON | Directeur/Membre du Conseil | 01/01/2018 |
| LapIQ | Fondateur | 01/01/2013 |
Formation de Widya Mulyasasmita
| Stanford University | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| Entreprise privées | 8 |
|---|---|
B Capital Group Management LP
B Capital Group Management LP Investment ManagersFinance B Capital Group Management LP is a private equity and venture capital firm founded in 2014 by Howard Lee Morgan, Raj Ganguly, Eduardo Saverin. The firm is headquartered in Manhattan Beach, California. | Finance |
Venn Biosciences Corp.
Venn Biosciences Corp. BiotechnologyHealth Technology Venn Biosciences Corp. engages in developing an artificial intelligence-driven mass spectrometry discovery and validation platform. Its products include VENN Vista, a glycoproteomic analysis; OpenPIP software, a neural network for automated mass spectrometry peak integration; and cancer liquid biopsy. The company was founded by Lieza Denan, Aldo Carrascoso, Carlito B. Lebrilla, and Carolyn R. Bertozzi in June 2017 and is headquartered in South San Francisco, CA. | Health Technology |
Oncomyx Therapeutics, Inc.
Oncomyx Therapeutics, Inc. Packaged SoftwareTechnology Services Oncomyx Therapeutics, Inc. develops and operates software platform to orchestrate an immune response and treat cancer. Its platform's features include non-human pathogen, immuno-stimulatory, ability to multi-arm, and systemic delivery. The company was founded by Steve Potts, Michael Wood, Grant McFadden and is headquartered in Phoenix, AZ. | Technology Services |
Red Tree Venture Capital
Red Tree Venture Capital Investment ManagersFinance Red Tree Venture Capital is a venture capital firm founded by Heath Lukatch. The firm is headquartered in portola, California. | Finance |
Triumvira Immunologics USA, Inc.
Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Commercial Services |
Partillion Bioscience Corp.
Partillion Bioscience Corp. Miscellaneous Commercial ServicesCommercial Services Partillion Bioscience Corp. is an American company that specializes in providing a functional single-cell biology reagent platform. The company's nanovial technology allows for single-cell secretion analysis and other research capabilities. The company was founded by Joseph Michael de Rutte and Dino Di Carlo, with Joseph Michael de Rutte serving as CEO since incorporation. | Commercial Services |
| OliLux Biosciences Inc | |
| LapIQ |
